Kalvista Pharmaceuticals Inc (CBYL) - Financial and Strategic SWOT Analysis Review

Summary

Kalvista Pharmaceuticals Inc (Kalvista), formerly Carbylan Therapeutics Inc is a pharmaceutical company that develops and markets biomaterial based therapies and medicals for the treatment of osteoarthritis. The companys products include hydros and hydros TA, which are used to treat knee osteoarthritis. Its hydros is a viscosupplementation therapy. Kalvistas hydros TA is a combination of hyaluronan and corticosteroid therapies. Its products are made from chemically engineered polymers of hyaluronic acid. The company develops products to treat the pain associated with osteoarthritis, a joint disorder including the degradation of the IA cartilage, joint lining, ligaments and, ultimately, and underlying bone. Kalvista is headquartered in Cambridge, Massachusetts, the US.

Kalvista Pharmaceuticals Inc Key Recent Developments

Mar 16,2017: KalVista Pharmaceuticals Reports Fiscal Third Quarter Results
Mar 09,2017: KalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President of Medical
Mar 17,2016: Carbylan Therapeutics Engages Wedbush PacGrow to Advise on Strategic Alternatives

This comprehensive SWOT profile of Kalvista Pharmaceuticals Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Kalvista Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents

Section 1 - About the Company

Kalvista Pharmaceuticals Inc - Key Information
Kalvista Pharmaceuticals Inc - Overview
Kalvista Pharmaceuticals Inc - Key Employees
Kalvista Pharmaceuticals Inc - Key Employee Biographies
Kalvista Pharmaceuticals Inc - Key Operational Heads
Kalvista Pharmaceuticals Inc - Major Products and Services
Kalvista Pharmaceuticals Inc - History
Kalvista Pharmaceuticals Inc - Company Statement
Kalvista Pharmaceuticals Inc - Locations And Subsidiaries
Kalvista Pharmaceuticals Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Kalvista Pharmaceuticals Inc - Business Description
Kalvista Pharmaceuticals Inc - Corporate Strategy
Kalvista Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Kalvista Pharmaceuticals Inc - Strengths
Kalvista Pharmaceuticals Inc - Weaknesses
Kalvista Pharmaceuticals Inc - Opportunities
Kalvista Pharmaceuticals Inc - Threats
Kalvista Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Kalvista Pharmaceuticals Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables



Kalvista Pharmaceuticals Inc, Key Information
Kalvista Pharmaceuticals Inc, Key Ratios
Kalvista Pharmaceuticals Inc, Share Data
Kalvista Pharmaceuticals Inc, Major Products and Services
Kalvista Pharmaceuticals Inc, History
Kalvista Pharmaceuticals Inc, Key Employees
Kalvista Pharmaceuticals Inc, Key Employee Biographies
Kalvista Pharmaceuticals Inc, Key Operational Heads
Kalvista Pharmaceuticals Inc, Other Locations
Kalvista Pharmaceuticals Inc, Subsidiaries
Kalvista Pharmaceuticals Inc, Key Manufacturing facilities
Kalvista Pharmaceuticals Inc, Key Competitors
Kalvista Pharmaceuticals Inc, SWOT Analysis
Kalvista Pharmaceuticals Inc, Ratios based on current share price
Kalvista Pharmaceuticals Inc, Annual Ratios
Kalvista Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures



Kalvista Pharmaceuticals Inc, Performance Chart
Kalvista Pharmaceuticals Inc, Ratio Charts

Kalvista Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kalvista Pharmaceuticals Ltd (Kalvista Pharma), formerly Kalvista Limited, is a pharmaceutical company which focuses on the discovery, development and commercialization of small molecule serine protease inhibitors. It develops a proprietary

USD 250 View Report

Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Rocket Pharmaceuticals Inc (Rocket Pharma), formerly Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of novel therapeutics for the treatment of glaucoma and

USD 300 View Report

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available